# Multiplexed TrAEL-seq captures DNA replication dynamics in mammalian cells

**Authors:** Neesha Kara, Laura Biggins, Alex Whale, Kieron May, Vera Grinkevich, Paola Garran-Garcia, Jhanavi Srinivasan, Peter J Rugg-Gunn, Claudia Ribeiro de Almeida, Samantha J Walker, Gabriele Picco, Mathew J Garnett, Simon Andrews, Aled Parry, Helen M R Robinson, Jonathan Houseley

PMC · DOI: 10.1093/nar/gkag212 · Nucleic Acids Research · 2026-03-14

## TL;DR

TrAEL-seq is improved to allow high-throughput analysis of DNA replication in mammalian cells without drugs or nucleotides.

## Contribution

The updated TrAEL-seq method enables multiplexing of up to six samples and provides high-resolution replication profiles.

## Key findings

- TrAEL-seq can be used in unsynchronized mammalian cells without nucleotide analogues.
- Replication fork speed is influenced by transcription and proximity to initiation zones.
- Forks accelerate after the first 1 Mb of replication, regardless of transcriptional activity.

## Abstract

TrAEL-seq is a robust method for profiling DNA replication genome-wide that works in unsynchronized cells and does not require drugs or nucleotide analogues. Here, we provide an updated method for TrAEL-seq that improves sample quality and includes multiplexing of up to six samples which dramatically improves throughput, and we validate TrAEL-seq in multiple mammalian cell lines. The updated protocol is straightforward and robust yet provides excellent resolution comparable to OK-seq in mammalian cell samples. High resolution replication profiles can be obtained across large panels of samples and in dynamic systems, for example during the progressive onset of oncogene induced senescence. In addition to mapping zones where replication initiates and terminates, TrAEL-seq is sensitive to replication fork speed, revealing effects of both transcription and proximity to replication Initiation Zones on fork progression. Although forks move more slowly through transcribed regions, this does not have a significant impact on the broader dynamics of replication fork progression, and instead replication forks accelerate across the first ∼1 Mb of travel irrespective of local transcriptional activity. We propose that this is a consequence of fewer replication forks being active later in S-phase when these distal regions replicate and there being less competition for replication factors.

Graphical Abstract

## Full-text entities

- **Genes:** Aicda (activation-induced cytidine deaminase) [NCBI Gene 11628] {aka Aid, Arp2}, SMARCAL1 (SNF2 related chromatin remodeling annealing helicase 1) [NCBI Gene 50485] {aka HARP, HHARP}, ATR (ATR checkpoint kinase) [NCBI Gene 545] {aka FCTCS, FRP1, MEC1, SCKL, SCKL1}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, SSB (small RNA binding exonuclease protection factor La) [NCBI Gene 6741] {aka LARP3, La, La/SSB, SSB/La}, AICDA (activation induced cytidine deaminase) [NCBI Gene 57379] {aka AID, ARP2, CDA2, HEL-S-284, HIGM2}, VTN (vitronectin) [NCBI Gene 7448] {aka V75, VN, VNT}, DNTT (DNA nucleotidylexotransferase) [NCBI Gene 1791] {aka TDT}
- **Diseases:** OIS (MESH:D000074723)
- **Chemicals:** streptomycin (MESH:D013307), Agarose (MESH:D012685), B0216S (-), MgSO4 (MESH:D008278), N-lauroyl sarcosine (MESH:C025231), ethanol (MESH:D000431), L-glutamine (MESH:D005973), chloroform (MESH:D002725), EdU (MESH:C022811), DAPI (MESH:C007293), paraformaldehyde (MESH:C003043), ethylenediaminetetraacetic acid (MESH:D004492), DRB (MESH:D004004), TE (MESH:D013691), TrAL (MESH:C015922), palbociclib (MESH:C500026), AZD6738 (MESH:C000611951), penicillin (MESH:D010406), phenol (MESH:D019800), Hydroxyurea (MESH:D006918), ATP (MESH:D000255), LPS (MESH:D008070), PG490 (MESH:C001899), ascorbic acid (MESH:D001205), CO2 (MESH:D002245), water (MESH:D014867), 4-hydroxy tamoxifen (MESH:C016601), PEG 8000 (MESH:C000595216), NaCl (MESH:D012965), 4OHT (MESH:C032278)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Escherichia coli (E. coli, species) [taxon 562], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932]
- **Mutations:** M5505S, M0538S, M0392S, E2610S, C) in 20, C in 100, C in 1, M0315L, M0373L
- **Cell lines:** IMR90 — Homo sapiens (Human), Finite cell line (CVCL_0347), PC9 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_B260), hESCs — Homo sapiens (Human), Embryonic stem cell (CVCL_UI95), IMR32 — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0346), R64-1-1 — Mus musculus (Mouse), Hybridoma (CVCL_C6IG), DLD-1 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0248), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), H9 — Homo sapiens (Human), Sezary syndrome, Cancer cell line (CVCL_1240), HCT116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), hESC — Homo sapiens (Human), Embryonic stem cell (CVCL_9771), RAS — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_B9UV), KM-12 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_1331), SW-48 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_1724)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12988324/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12988324/full.md

## References

64 references — full list in the complete paper: https://tomesphere.com/paper/PMC12988324/full.md

---
Source: https://tomesphere.com/paper/PMC12988324